Requip and Yaz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Requip (ropinirole hydrochloride) and Yaz (drospirenone; ethinyl estradiol). Common drug interactions include deep vein thrombosis among females and cholelithiasis among males.

The phase IV clinical study analyzes what interactions people have when they take Requip and Yaz. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.

What is Yaz?

Yaz has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 41,514 Yaz users. Check the latest studies of Yaz.



On Jul, 08, 2026

62 people who take Requip and Yaz together, and have interactions are studied.

Requip and Yaz drug interactions.

What are the common drug interactions of Requip and Yaz, by gender? *:

female:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Gallbladder disorder
  3. Abdominal pain
  4. Abdominal pain upper
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Cholecystitis chronic (long lasting infection of gallbladder)
  7. Migraine (headache)
  8. Vomiting
  9. Cerebral infarction (less blood supply to brain resulting tissue damage)
  10. Headache (pain in head)

male:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Gallbladder injury

What are the common drug interactions of Requip and Yaz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Clonic convulsion (long lasting seizure)
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Hyperventilation
  4. Incoherent (talking in a confused and unclear way)
  5. Loss of consciousness
  6. Migraine (headache)
  7. Partial seizures (seizures which affect only a part of the brain at onset)
  8. Tremor (trembling or shaking movements in one or more parts of your body)

20-29:

  1. Pain
  2. Injury
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Brain compression
  5. Cerebellar infarction (impaired blood circulation to cerebellum)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Cholecystitis chronic (long lasting infection of gallbladder)
  8. Emotional distress
  9. Anxiety
  10. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

30-39:

  1. Pain
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Injury
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Anxiety
  6. Emotional distress
  7. Cholecystitis chronic (long lasting infection of gallbladder)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Gallbladder disorder
  10. Abdominal pain upper

40-49:

  1. Headache (pain in head)
  2. Abdominal pain upper
  3. Apraxia (disorder that affects a person's ability to organize the movements of the muscles used in speech)
  4. Biliary colic
  5. Clumsiness (a lack of coordination or elegance)
  6. Gallbladder disorder
  7. Migraine (headache)
  8. Muscular weakness (muscle weakness)
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Speech disorder

50-59:

  1. Pain
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Abdominal pain
  4. Abdominal pain lower
  5. Abdominal pain upper
  6. Colitis (inflammation of colon)
  7. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  8. Decreased appetite
  9. Diarrhoea haemorrhagic (bloody diarrhoea)
  10. Drug hypersensitivity

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Abdominal pain
  3. Balance disorder
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Bradyarrhythmia (heart slowness)
  6. Cerebral atrophy (decrement in size of brain)
  7. Cerebral haematoma (collection of blood in brain)
  8. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Chest pain

What are the existing conditions these people have? *

  1. Pain: 15 people, 24.19%
  2. Acne (skin problems that cause pimples): 10 people, 16.13%
  3. Migraine (headache): 7 people, 11.29%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 8.06%
  5. Depression: 5 people, 8.06%
  6. Stress And Anxiety: 4 people, 6.45%
  7. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 6.45%
  8. High Blood Cholesterol: 4 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Requip and Yaz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Requip and Yaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Requip:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Yaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Requip and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Yaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ropinirole hydrochloride and drospirenone; ethinyl estradiol (the active ingredients of Requip and Yaz, respectively), and Requip and Yaz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: